JPRN-UMIN000033132
Completed
未知
Phase II trial of stereotactic body radiotherapy for non-spine bone metastases. - SBRT for non-spine bone mets.
Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital0 sites35 target enrollmentJune 25, 2018
Conditionsnon-spine bone metastases
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- non-spine bone metastases
- Sponsor
- Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital
- Enrollment
- 35
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. The lesion is skull base bone 2\. The lesion is radiosensitive tumor 3\. Radiation history in the same area with 3 months 4\. Serious medical or psychological problems
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Phase II trial of stereotactic body radiotherapy with a hydrogel spacer for prostate cancerProstate cancerJPRN-UMIN000026213The University of Tokyo Hospital42
Active, not recruiting
Phase 1
Phase I trial of stereotactic body radiotherapy with concurrent pembrolizumab in metastatic urothelial cancer.Metastatic urothelial cancerTherapeutic area: Diseases [C] - Cancer [C04]EUCTR2016-001263-37-BEZ Gent20
Completed
Phase 1
A phase I trial of stereotactic body radiotherapy for limited hepatocellular carcinomaHepatocellular carcinomaJPRN-UMIN000003090Division of Radiation Oncology and division of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan12
Recruiting
Phase 1
Phase I study of postoperative stereotactic body radiotherapy for prostate cancerJPRN-jRCT1030220062Yamashita Hideomi36
Recruiting
Phase 1
Phase I/II study of stereotactic radiotherapy for renal cell cancerJPRN-UMIN000004172niversity of Yamanashi30